Insulin Enquiry (Monopolies & Restrictive Practices Act): documents for the information of Markby, Stewart & Wadesons

List of documents suggested for the information of Markby, Stewart & Wadesons.

Notes on manufacturing processes (1941) for insulin (British Drug Houses Ltd and Boots Pure Drug Co Ltd).

Memorandum (1951) prepared for submission to the Monopolies & Restrictive Practices Commission (3rd Proof, marked "Final").

Minutes of Special Meetings (1941-50) of British Insulin Manufacturers, supplied for the information of Markby, Stewart & Wadesons.

Copy Memorandum and Articles of Association of The Wellcome Foundation Ltd (1924).

Memorandum (29 February, 1932) by Henry Wellcome: "Policy and Aims for the Guidance and Assistance of my Trustees". Refers to a number of matters, including "Model Works Village" (elsewhere referred to as "Wellcomeville").

Copy Deed of Covenant (30 July, 1936), between George Henry Hudson Lyall, Sir Henry Hallett Dale, Lancelot Claude Bullock, Martin Price, and Thomas Renton Elliott.

Duplicate Order (21 December, 1936), concerning Henry Wellcome deceased. Lyall v Dale.

Copy Deed of Covenant (13 January, 1937) between George Henry Hudson Lyall, Sir Henry Hallett Dale, Lancelot Claude Bullock, Martin Price, and Thomas Renton Elliott.

Duplicate Order (1 May, 1939), concerning Wellcome Will Trusts. Sir Henry Hallett Dale and others v His Majesty's Attorney General.

Duplicate Order (12 January, 1944), concerning Wellcome deceased. Dale v His Majesty's Attorney General.

"The Manufacture of Insulin," The Chemist and Druggist Export Review (January, 1949).

The purpose of the Enquiry was to ensure that supplies of insulin were available to the diabetic community without interruption, despite the constraints of war. Manufacturers exchanged full technical information about their processes and visited each other's manufacturing plants.

1924-1951

1 file

WF/BIM.

Copyright assigned to the Wellcome Trust